Skip to main content

Table 3 Health resource used for IPF management (including AE-IPF) during follow-up, according to baseline predicted FVC%

From: Clinical management and acute exacerbations in patients with idiopathic pulmonary fibrosis in Spain: results from the OASIS study

Health resource

Total

N = 191

FVC < 50%

N = 19

FVC 50–80%

N = 144

FVC > 80%

N = 28

P value

Visits

Patients who required primary care visits, n (%)

59 (30.9%)

9 (47.4%)

43 (29.9%)

7 (25.0%)

0.2296

Number of visits to primary care, mean (SD)

0.97 (2.13)

2.47 (3.29)

0.86 (2.03)

0.50 (1.00)

0.0570

Patients who required specialized care visits, n (%)

187 (97.9%)

17 (89.5%)

143 (99.3%)

27 (96.4%)

0.0275

 Pulmonologist

187 (97.9%)

17 (89.5%)

143 (99.3%)

27 (96.4%)

0.0275

 Nurse

59 (30.9%)

4 (21.1%)

42 (29.2%)

13 (46.4%)

0.1207

 Nutritionist

5 (2.6%)

2 (10.5%)

2 (1.4%)

1 (3.6%)

0.0598

 Psychiatrist

7 (3.7%)

1 (5.3%)

5 (3.5%)

1 (3.6%)

0.8105

 Psychologist

3 (1.6%)

0 (0.0%)

2 (1.4%)

1 (3.6%)

0.5737

 Other health professionala

37 (19.4%)

5 (26.3%)

26 (18.1%)

6 (21.4%)

0.6629

 Respiratory rehabilitation

16 (8.4%)

4 (21.1%)

9 (6.3%)

3 (10.7%)

0.0611

 Nursing home visit

3 (1.6%)

1 (5.3%)

1 (0.7%)

1 (3.6%)

0.1504

 Smoking consult cessation

1 (0.5%)

0 (0.0%)

1 (0.7%)

0 (0.0%)

1.0000

Patients who required emergency visits, n (%)

46 (24.1%)

11 (57.9%)

31 (21.5%)

4 (14.3%)

0.0412

Primary care areab

15 (32.6%)

4 (36.4%)

10 (32.3%)

1 (25.0%)

0.0055

Hospital care areab

38 (82.6%)

8 (72.7%)

27 (87.1%)

3 (75.0%)

1.0000

Hospitalizations

Patients who required a hospital admission due to IPF, n (%)c

29 (15.2%)

9 (47.4%)

17 (11.8%)

3 (10.7%)

0.0010

Number of hospitalizations/patient, mean (SD)

0.34 (0.96)

0.89 (1.24)

0.28 (0.93)

0.29 (0.76)

0.0010

Days of hospitalization, mean (SD)

8.25 (7.23)

13.53 (10.01)

6.26 (4.73)

5.71 (3.04)

0.0059

Patients who were admitted to ICU, n (%)d

6 (11.3%)

3 (20.0%)

3 (9.7%)

0 (0.0%)

0.4573

Days in ICU, mean (SD)

12.17 (8.57)

10.00 (8.66)

14.33 (9.71)

–

0.3758

Patients who required intubation during ICU admission, n (%)e

5 (83.3%)

3 (100.0%)

2 (66.7%)

–

1.0000

Tests

Patients who required laboratory tests, n (%)f

167 (87.4%)

18 (94.7%)

127 (88.2%)

22 (78.6%)

0.2231

Patients who required pulmonary function tests, n (%)g

161 (84.3%)

12 (63.2%)

127 (88.2%)

22 (78.6%)

0.0125

Other tests, n (%)h

88 (46.1%)

7 (36.8%)

65 (45.1%)

16 (57.1%)

0.3529

  1. In bold, p-values < 0.05
  2. FVC forced vital capacity, ICU intensive care unit, IPF idiopathic pulmonary fibrosis, NIMV non-invasive mechanical ventilation, SD standard deviation
  3. aIncludes: allergist, anesthesiologist, cardiologist, surgeon, dermatologist, digestive, endocrine, hospital pharmacy/pharmacy, physiotherapist, hematologist, internist, nephrologist, neurologist, preventive/preventive medicine, radiologist, rheumatologist, urologist
  4. bOver total number of patients who required emergency visits in the total sample (n=46), and in each FVC% predicted group
  5. cA total of 29 patients required 53 hospital admissions due to IPF
  6. dOver total number hospital admissions in each group
  7. eOver total number ICU admissions in each group
  8. fIncluded: hemogram, biochemistry, coagulation profile, erythrocyte sedimentation rate, liver profile, angiotensin converting enzyme, rheumatoid factor, antinuclear antibodies, C-reactive protein, procalcitonin, natriuretic peptide, dimer D and “another test”
  9. gIncluded: spirometry, pulmonary plethysmography, carbon monoxide diffusion capacity, 6-min walk test, and “another test”
  10. hIncluded: X-Ray, High resolution computed tomography (HRCT), bronchoscopy, bronchoalveolar lavage, transbronchial biopsy, arterial blood gases, PCR, and “another test”
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us